Grifols
Sign in to saveAlso known as Grifols, S.A., Grifols Therapeutics LLC
alt=Grifols headquarters in Sant Cugat del Vallès (Barcelona)|thumb|Grifols headquarters in Sant Cugat del Vallès (Barcelona) Grifols, S.A. () is a global healthcare company and leading producer of plasma-derived medicines founded in Barcelona, Catalonia, Spain, in 1909. With a workforce of over 23,800 employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over than 30.
Key facts
- Company.name
- Grifols, S.A.
- Company.logo
- Grifols.svg
- Company.logo_size
- 230px
- Company.type
- Public
- Company.industry
- Healthcare
- Company.products
- Plasma-derived medicines to treat chronic, rare and prevalent diseases, tools and services for hospitals, pharmacies and healthcare professionals.
- Company.revenue
- €7.2 billion (2024)
- Company.num_employees
- More than 23,800 (2024)
- Company.hq_location
- Sant Cugat del Vallès (Barcelona, Catalonia, Spain)
via Wikipedia infobox
Research organization · ROR
- Type
- Company, Funder
- Founded
- 1940
- Location
- Barcelona, Spain
- Status
- Active
GRID grid.425602.7 · ISNI 0000 0004 1765 2224
~9 min read
Encyclopedic overview
10 sectionsContents
- History
- Stock Listings
- Acquisitions
- Strategic Alliances
- Main products
- Industrial operations
- Research
- Controversy
- References
- External links
alt=Grifols headquarters in Sant Cugat del Vallès (Barcelona)|thumb|Grifols headquarters in Sant Cugat del Vallès (Barcelona) Grifols, S.A. () is a global healthcare company and leading producer of plasma-derived medicines founded in Barcelona, Catalonia, Spain, in 1909. With a workforce of over 23,800 employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over than 30.
Principally a producer of blood plasma–based products and other biopharmaceuticals, the company also operates in transfusion medicine, supplying devices, instruments and reagents for clinical testing laboratories, as well as clinical diagnostic technologies. Furthermore, it provides biological supplies for life-science research, clinical trials and the manufacturing of pharmaceutical and diagnostic products. It has a portfolio on four therapeutic areas: immunology, infectious diseases, pulmonology and critical care.
Excerpted from Wikipedia’s “Grifols” article, available under the CC BY-SA 4.0 licence.